Skip to main content
MS-DRG 147 · MDC 03 · Medical

MS-DRG 147: Ear, Nose, Mouth and Throat Malignancy with CC

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: IPPS Table 5 (MS-DRG weights): v44 FY2027 (final rule + CN3) (effective October 1, 2026); MS-DRG Definitions Manual: v44 (effective October 1, 2026). Next CMS release: FY2028 final rule (August 2027), effective October 1, 2027; an April 1 interim grouper update when CMS issues one for the IPPS Table 5 (MS-DRG weights); the FY2028 grouper, effective October 1, 2027 for the MS-DRG Definitions Manual.

Key facts for DRG 147

FY2027 relative weight
1.3055
Higher than 35% of all MS-DRGs
Change vs FY2026
+2.7%
FY2026 weight 1.2715
Geometric mean LOS
3.5 days
Arithmetic mean 4.9 days
MDC
03
Diseases and Disorders of the Ear, Nose, Mouth and Throat
Severity level
with CC (complication or comorbidity)
National unadjusted operating payment
$8,940.06
Weight × $6,848.00 FY2027 standardized amount; capital adds $704.90
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 147 is a medical group in MDC 03 (Diseases and Disorders of the Ear, Nose, Mouth and Throat), at the middle of three severity levels in its CC/MCC family. CMS assigns it a FY2027 relative weight of 1.3055 with a geometric mean length of stay of 3.5 days and an arithmetic mean of 4.9. Its weight moved up 2.7% from FY2026 (1.2715). That weight is higher than 35% of all MS-DRGs. Its weight sits 38.8% below DRG 146 (with MCC, 2.1329) and 63.0% above DRG 148 (without CC/MCC, 0.8008). The v44 Definitions Manual assigns it through 102 principal diagnosis codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 147 the FY2027 relative weight is 1.3055 against 1.2715 in FY2026, a rise of 2.67%, which exceeds the 2% threshold worth re-checking in contract models.

FY2026 versus FY2027 payment factors for MS-DRG 147
MetricFY2026FY2027Change
Relative weight1.27151.3055+0.0340
Geometric mean LOS (days)3.53.5+0.0
Arithmetic mean LOS (days)4.84.9+0.1
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 147 shares its base definition with 2 other MS-DRGs split by severity. The family's weights span 0.8008 to 2.1329, a 2.66× spread, which is the payment effect of documenting qualifying complications and comorbidities.

MS-DRGs in the same base group as DRG 147
DRGTitleFY2027 weightGMLOSNational operating payment
146Ear, Nose, Mouth and Throat Malignancy with MCC2.13295.6$14,606.10
147Ear, Nose, Mouth and Throat Malignancy with CC1.30553.5$8,940.06
148Ear, Nose, Mouth and Throat Malignancy without CC/MCC0.80082.2$5,483.88

At the national rate, documenting the family's top severity level (DRG 146, $14,606.10) instead of its base level (DRG 148, $5,483.88) changes the operating payment by $9,122.22. The figures are national operating amounts before the hospital-specific adjustments described below.

National unadjusted payment for DRG 147

Multiplying the FY2027 relative weight (1.3055) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. Across the CC/MCC family the operating amount spans $9,122.22.

FY2027 national unadjusted IPPS payment for MS-DRG 147
ComponentNational rateDRG 147
Operating (labor and nonlabor share)$4,519.68 + $2,328.32 = $6,848.00$8,940.06
Capital (federal rate)$539.95$704.90
Operating plus capital$9,644.96
Assumes the full annual update (the hospital submitted quality data and is a meaningful EHR user). A hospital with a reduced update starts from $8,660.41 to $8,870.15 for the operating portion of this DRG.

These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 147.

Risk-adjusting diagnoses in this DRG

Appendix B of the v44 Definitions Manual lists 102 ICD-10-CM codes in the logic for DRG 147; 73 of them also map to a CMS-HCC V28 payment category, across 2 categories. The same documentation that supports the inpatient group feeds Medicare Advantage risk adjustment when the patient is an MA enrollee.

CMS-HCC V28 categories among the diagnoses in the logic for DRG 147
V28 HCCCategoryShared codesExamples
HCC 21Lymphoma and Other Cancers72C01, C02.0, C02.1
HCC 23Prostate, Breast, and Other Cancers and Tumors1C76.0

Grouper logic (v44 Definitions Manual)

The manual's split table for Ear, Nose, Mouth and Throat Malignancy gives one row per combination of criteria and the MS-DRG it assigns. DRG 147 is the row where MCC is No, CC is Yes.

Split table for Ear, Nose, Mouth and Throat Malignancy
MCCCCDRG
Yesnot checked146
NoYes147
NoNo148

Principal Diagnosis: 102 ICD-10-CM codes in this DRG's assignment logic; the first 12 are shown.

Principal Diagnosis codes in the logic for DRG 147 (sample)
ICD-10-CM codeDescription
C00.0Malignant neoplasm of external upper lip
C00.1Malignant neoplasm of external lower lip
C00.2Malignant neoplasm of external lip, unspecified
C00.3Malignant neoplasm of upper lip, inner aspect
C00.4Malignant neoplasm of lower lip, inner aspect
C00.5Malignant neoplasm of lip, unspecified, inner aspect
C00.6Malignant neoplasm of commissure of lip, unspecified
C00.8Malignant neoplasm of overlapping sites of lip
C00.9Malignant neoplasm of lip, unspecified
C01Malignant neoplasm of base of tongue
C02.0Malignant neoplasm of dorsal surface of tongue
C02.1Malignant neoplasm of border of tongue

Code editor, HAC and CC/MCC exclusion notes for DRG 147

Because this family splits by CC and MCC, a secondary diagnosis on the hospital-acquired condition list that is reported with a present-on-admission indicator of N or U does not count toward the severity level, and a CC or MCC excluded by the principal diagnosis does not count either. Check a secondary diagnosis and its CC exclusion before relying on it for the higher member.

Documentation and denial exposure

As a medical DRG, assignment depends on the principal diagnosis sequenced from the attending's documentation; a secondary condition sequenced first, or a symptom code in place of the confirmed diagnosis, changes the MDC or the DRG. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

For teams evaluating QuickIntell software

Evaluate a documentation and coding workflow for DRG 147

Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — DRG 147

What is MS-DRG 147?

MS-DRG 147 is "Ear, Nose, Mouth and Throat Malignancy with CC", a medical Medicare Severity Diagnosis-Related Group in MDC 03 (Diseases and Disorders of the Ear, Nose, Mouth and Throat). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 147?

The FY2027 relative weight is 1.3055 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 1.2715, a change of +2.7%.

What is the Medicare base payment for MS-DRG 147?

$8,940.06 for operating costs plus $704.90 for capital, $9,644.96 together, at the FY2027 national rates: weight 1.3055 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). DRG 146 (with MCC) comes to $14,606.10 operating on the same basis. DRG 148 (without CC/MCC) comes to $5,483.88 operating on the same basis. The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.

What is the average length of stay for DRG 147?

CMS reports a geometric mean length of stay of 3.5 days and an arithmetic mean of 4.9 days for FY2027. The geometric mean is used for transfer-payment calculations.

Which DRGs are in the same CC/MCC family as 147?

DRG 146 (with MCC, weight 2.1329, GMLOS 5.6 days); DRG 148 (without CC/MCC, weight 0.8008, GMLOS 2.2 days). Together with DRG 147 the family spans 0.8008 to 2.1329, a 2.66x spread, so documented complications and comorbidities change payment materially.

What documentation supports the severity level of DRG 147?

DRG 147 is reached when the stay carries a secondary diagnosis from the CMS Complication or Comorbidity list but none from the MCC list. Common CC captures include chronic kidney disease stage 3 and above, uncontrolled diabetes with manifestations, malnutrition of specified severity and heart failure of a stated type. Each must be documented by the treating clinician and show clinical relevance in the record; a condition listed only in the problem list without assessment is the most frequent reason a CC is removed on audit and the stay drops to the base DRG.

Which codes group to DRG 147?

The v44 Definitions Manual lists 102 principal diagnosis codes for this group. Examples from the principal diagnosis list, C00.0 (Malignant neoplasm of external upper lip); C00.1 (Malignant neoplasm of external lower lip); C00.2 (Malignant neoplasm of external lip, unspecified); C00.3 (Malignant neoplasm of upper lip, inner aspect).

Is DRG 147 a post-acute transfer DRG?

No. DRG 147 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.